6/10
07:30 am
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
5/25
08:36 am
tnya
We're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate [Yahoo! Finance]
5/16
12:19 pm
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $16.00. They now have a "buy" rating on the stock.
Low
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $16.00. They now have a "buy" rating on the stock.
5/15
12:24 pm
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Medium
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
5/14
04:16 pm
tnya
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/14
04:05 pm
tnya
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
5/10
01:31 pm
tnya
Gladstone's Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times [Yahoo! Finance]
Low
Report
Gladstone's Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times [Yahoo! Finance]
5/2
05:08 pm
tnya
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting [Yahoo! Finance]
Low
Report
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting [Yahoo! Finance]
5/2
05:00 pm
tnya
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
Low
Report
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
4/24
01:03 pm
tnya
HDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
Low
Report
HDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
4/14
10:07 am
tnya
Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company [Yahoo! Finance]
Low
Report
Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company [Yahoo! Finance]
3/21
01:42 pm
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Low
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
3/20
08:08 am
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $19.00 to $18.00. They now have a "buy" rating on the stock.
High
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $19.00 to $18.00. They now have a "buy" rating on the stock.